I. Nakae et al., Effects of intravenous nicorandil on coronary circulation in humans: Plasma concentration and action mechanism, J CARDIO PH, 35(6), 2000, pp. 919-925
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
We investigated the cardiovascular profile of nicorandil, an antianginal ag
ent, in humans. Pharmacologically, nicorandil acts as both an adenosine tri
phosphate (ATP)sensitive K+ (K-ATP) channel opener and a nitrate. We examin
ed which of these mechanistic components has a predominant vasodilatory eff
ect at clinical doses. Fourteen patients underwent cardiac catheterization.
The effects of the continuous intravenous infusion of nicorandil (12 mg/45
min) were examined in angiographically normal coronary arteries. Coronary
vascular resistance was calculated from coronary artery diameter and corona
ry blood flow velocity measured using an intravascular Doppler catheter. We
compared the hemodynamic responses to nicorandil with those to the intraco
ronary injection of nitroglycerin (250 mu g) and papaverine (12 mg). The ep
icardial coronary arteries responded to nicorandil at the lowest plasma con
centration examined (dilation of +14.0 +/- 3.3% at similar to 170 ng/ml); w
hereas dilation of the coronary resistance arteries (i.e., a decrease in co
ronary vascular resistance) took place only at higher concentrations (>200
ng/ml). Nitroglycerin caused no further changes in coronary artery diameter
or coronary vascular resistance. Papaverine caused no further increase in
coronary artery diameter, but markedly decreased coronary vascular resistan
ce (1.6 +/- 0.3 to 0.4 +/- 0.1 mm Hg/ml/min; p < 0.05). Nicorandil signific
antly decreased pulmonary capillary wedge pressure (i.e., reduced cardiac p
reload) at a plasma level of >200 ng/ml, but did not change either systemic
or pulmonary vascular resistance. Thus nicorandil preferentially dilated e
picardial coronary arteries rather than coronary resistance arteries, and h
ad a stronger effect on preload than on afterload. These changes in human c
oronary hemodynamics suggest that the nitrate actions of nicorandil as a co
ronary vasodilator predominate over those as a K-ATP opener.